MedPath

Effects of alpha-lipoic acid supplementation in women with gestational diabetes

Phase 2
Conditions
Gestational diabetes mellitus.
Diabetes mellitus arising in pregnancy
Registration Number
IRCT2017091225949N5
Lead Sponsor
Vice Chancellor for research of Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

No history of GDM and not consumption of vitamin and mineral supplements during the last 6 months. Exclusion criteria: Preterm delivery; preeclampsia; the need for insulin or oral medication for lowering blood sugar during the intervention; bed rest; alcoholism and smoking.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting glucose. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Colorimetric.;Fasting insulin. Timepoint: Before and after 8 weeks of intervention. Method of measurement: ELISA.;Fasting leptin. Timepoint: Before and after 8 weeks of intervention. Method of measurement: ELISA.;Fasting adiponectin. Timepoint: Before and after 8 weeks of intervention. Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
BMI. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Formula.
© Copyright 2025. All Rights Reserved by MedPath